Jul 20,2023

AppliedVR and National Cancer Institute Collaborate on Research Evaluating Virtual Reality for Reducing Anxiety in Primary Brain Tumor Patients During Imaging Services

AppliedVR, in collaboration with the National Cancer Institute (NCI), conducted a phase 2 clinical trial using virtual reality (VR) as an intervention for primary brain tumor patients, showing high feasibility and acceptability. VR therapy was found to positively impact patients' distress and anxiety levels.

COLLABORATION PARTNERSHIP

#r&d

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Jun 27,2023

The Peplinski Group Brings MyndVR to its Managed Senior Care Communities

MyndVR has partnered with The Peplinski Group to bring VR technology to its 10 managed senior care communities in Michigan. This partnership will introduce MyndVRx, a specialized portfolio of VR therapy tools designed with Select Rehab, Orio Cognitive, and powered by the all new XR Elite immersive glasses by HTC Vive to enhance the lives of seniors through engaging and rewarding virtual reality experiences.

COLLABORATION PARTNERSHIP

#institution

#virtual reality

View Analyst & Ambassador Comments
Go to original news
May 24,2023

Tennessee Receives Largest BVL Grant to Deploy MyndVR Across All TN State Veteran Homes

MyndVR secures a significant BVL grant to deploy virtual reality glasses across Tennessee State Veteran Homes, benefiting over 10,000 veterans. The grant, in collaboration with the National Association of State Veteran's Homes, marks a milestone in providing innovative digital therapeutic experiences. MyndVR's immersive glasses offer emotional, cognitive, and physical benefits, improving healthcare outcomes while reducing costs. This advancement aligns with the bipartisan Access to Prescription Digital Therapeutics Act, recognizing the necessity of scalable and evidence-based digital therapeutics.

FUNDING GRANT

#virtual reality

View Analyst & Ambassador Comments
Go to original news
May 12,2023

Rocket VR Health announces corporate re-branding and changes name to "Novobeing"

Virtual reality company, Rocket VR Health, has rebranded to Novobeing, marking a shift towards non-clinical wellness applications to augment its evidence-based VR digital therapeutics. Novobeing has developed innovative digital therapeutics for reducing distress and anxiety in patients undergoing long hospital stays and is currently conducting three clinical trials to study and improve the efficacy of its virtual reality digital therapeutics.

#virtual reality

#cbt

View Analyst & Ambassador Comments
Go to original news
Mar 21,2023

AT&T Joins MyndVR's DigitalTherapyNow.org as Coalition Supporter to Promote Passage of Digital Therapeutics Bill

MyndVR, the provider of therapeutic VR experiences designed for the aging population, today announced AT&T's support of the DigitalTherapyNow.org initiative. This purpose-driven alliance of academic and industry partners was designed to educate lawmakers in the effort to pass the bipartisan Access to Prescription Digital Therapeutics Act of 2023. AT&T stands alongside other industry leaders supporting this effort, including the XR Association (XRA), HTC, Select Rehabilitation, International VR Healthcare Association (IVRHA), and the National Association of State Veteran Homes (NASVH). The bipartisan legislation, proposed by Reps. Mike Thompson (CA-05) and Kevin Hern (OK-01) and Sens. Jeanne Shaheen (D-NH) and Shelley Moore Capito (R-WV), aims to officially define prescription digital therapeutics (PDTx) at the federal level and establish new payor benefits to treat a broad range of age-related health conditions. The bill was reintroduced on March 7, 2023.

COLLABORATION PARTNERSHIP

#institution

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Mar 21,2023

AppliedVR Becomes First Virtual Reality Provider to Receive HCPCS Level II Code from Centers for Medicare and Medicaid Services as Durable Medical Equipment

AppliedVR, an immersive therapeutics (ITx) company, has become the first virtual reality provider to receive a Healthcare Common Procedure Coding System (HCPCS) Level II code from the Centers for Medicare and Medicaid Services (CMS) for its flagship product, the RelieVRx program. The HCPCS code, which categorizes the program as durable medical equipment (DME), allows AppliedVR's digital therapeutic (DTx) solution to have a clearer pathway for securing Medicare coverage eligibility and could influence commercial coverage more broadly. The RelieVRx program provides virtual reality cognitive behavioral therapy (CBT) to treat chronic low back pain and was the first VR-based therapeutic to receive FDA authorization

PRODUCT

#virtual reality

#reimbursement

#cbt

View Analyst & Ambassador Comments
Go to original news
Mar 07,2023

MyndVR and Stage Access Team to Bring Classical Music and Performances to Virtual Reality Therapy for Older Adults

MyndVR, a virtual reality (VR) platform for seniors, has partnered with Stage Access, an online platform for classical music, to provide immersive musical experiences to older adults in virtual reality therapy. The partnership will allow MyndVR to integrate Stage Access’ extensive classical music library into its VR platform, giving seniors access to concerts, operas, and other performances from around the world. The experience will be designed to enhance cognitive function, memory, and overall well-being among seniors.

COLLABORATION PARTNERSHIP

#product & service

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Mar 07,2023

Rocket VR Health and Massachusetts General Hospital Announce Initiation of Randomized Control Trial Investigating Efficacy of Virtual Reality Digital Therapeutic

Virtual reality digital therapeutics company Rocket VR Health (RVH) has launched a randomized control trial with Massachusetts General Hospital (MGH). The 80-patient study will evaluate the feasibility and preliminary efficacy of RVH's virtual reality digital therapeutic in adult patients with blood cancers admitted for hematopoietic stem cell transplantation at MGH. The study aims to improve the quality of life, symptom burden, psychological distress and self-efficacy of patients who experience immense physical and psychological symptoms during a prolonged four-week hospitalization. RVH and MGH partnered in early 2021 to develop the evidence-based VR solution, which leverages lessons learned from evidence-based palliative care interventions for patients undergoing HCT that were studied for years by the MGH team. The comprehensive 4-week therapeutic intervention combines interactive therapeutic experiences, high-definition doctor holograms, and meditations. The study will guide RVH towards validating the efficacy of its digital therapeutic and help build a go-to distress management solution for hospitalized patients.

COLLABORATION PARTNERSHIP

#r&d

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Feb 16,2023

VA awards OxfordVR $500,000 in Mission Daybreak grand challenge to reduce Veteran suicides

The U.S. Department of Veterans Affairs has named OxfordVR as a winner in Mission Daybreak — a $20 million challenge designed to help VA develop new suicide prevention strategies for Veterans. As a third-place award winner, OxfordVR, which recently came under the BehaVR umbrella, will receive $500,000 to further support the company's work in developing virtual reality (VR) solutions to address mental and behavioral health challenges in support of Veterans.

FUNDING GRANT

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Jul 09,2020

Self-Administered Skills-Based Virtual Reality Intervention for Chronic Pain: Randomized Controlled Pilot Study

Patients with chronic pain often have limited access to comprehensive care that includes behavioral pain management strategies. Virtual reality (VR) is an immersive technology and emerging digital behavioral pain therapy with analgesic efficacy for acute pain. We found no scientific literature on skills-based VR behavioral programs for chronic pain populations.

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news